← Back to Search

Behavioural Intervention

IA3-CP only for Bladder Cancer

N/A

Recruiting

Led By Russell E Glasgow

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age > /= 65

Age greater than or equal to 65

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 months

Awards & highlights

Study Summary

This trial aims to develop and test a new system called Integrated Aging Assessment for Action for Cancer Patients (IA3-CP) that will assess geriatric issues, health behaviors, mental health, and social

Who is the study for?

This trial is for cancer patients aged 65 or older who speak English or Spanish and are attending their initial oncology visit. They must be willing to participate in all study activities. It's open to those with various cancers, including leukemia, multiple myeloma, kidney tumors, breast cancer, Hodgkin's lymphoma, prostate cancer, and bladder cancer.Check my eligibility

What is being tested?

The trial tests an assessment tool called IA3-CP designed to integrate geriatric issues, health behaviors, mental health assessments along with social determinants of health (SDoH). Patients will either receive the IA3-CP with SDoH considerations or without them to see how well these tools can be implemented and improve care.See study design

What are the potential side effects?

Since this trial involves an assessment tool rather than a medication or medical procedure, traditional physical side effects are not expected. However participants may experience discomfort discussing personal matters related to their health behaviors or mental health.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 years old or older.

Select...

I am 65 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of referrals made and completed for geriatric, health behavior and SDoH issues

Patient reported receipt of quality illness care

Secondary outcome measures

Discussion of IA3-CP related issues in oncologist-patient encounter

Oncologist utility

Proportion of patients that use IA3-CP screening tool

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: IA3-CP with SDoHExperimental Treatment1 Intervention

Assess IA3-CP with SDoH and provide feedback (provider & patient)

Group II: IA3-CP onlyExperimental Treatment1 Intervention

Assess IA3-CP only without added SDoH and provide feedback (provider & patient)

Group III: Control - usual careActive Control1 Intervention

Usual care: Assess IA3-CP without providing the feedback report

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,491 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,672 Previous Clinical Trials

40,926,406 Total Patients Enrolled

Russell E GlasgowPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost limit for participant enrollment in this research endeavor?

"Indeed, the details found on clinicaltrials.gov highlight that this investigation is actively seeking suitable participants. The trial was initially disclosed on December 1st, 2024 and most recently revised on February 2nd, 2024. Specifically, the study aims to enroll a total of 35 individuals at one designated site."

Answered by AI

Are participants currently being recruited for this research study?

"Indeed, data available on clinicaltrials.gov highlights the ongoing patient recruitment for this trial. The study was first listed on 1st December 2024 and had its latest update on 2nd February 2024. A total of 35 participants are being sought from a single designated site."

Answered by AI

Can individuals who have not yet reached the age of 18 participate in this study?

"Prospective participants must be between the ages of 65 and 111 to meet the eligibility criteria for this study. There are a total of 609 clinical trials available for individuals below 18 years old, as well as 4331 trials catering to those aged over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Integrated Actionable Aging Assessment for Cancer Patients Pilot

2024. "Integrated Actionable Aging Assessment for Cancer Patients Pilot". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05871008.

All > Leukemia